Business ❯Pharmaceutical Industry

Biotechnology

Clinical Research Acquisitions

First Death Reported in Patient Using Sarepta's Duchenne Gene Therapy

Sarepta Therapeutics investigates acute liver failure case, leading to a 23% stock drop and plans to update prescribing information.

FDA Rejects MDMA-Assisted Therapy for PTSD, Citing Insufficient Evidence